The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why ...

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

Kimberly-Clark (KMB) shares have edged lower in recent trading, catching investors’ attention as the company’s performance trends have lagged over the past month. The stock’s nearly 17% slide in that ...

Kimberly-Clark (NASDAQ:KMB) is making a massive bet but investors aren't sure on how to feel about it. The maker of Kleenex ...

The consumer health and wellness giants are both Dividend Kings, with more than 50 years of consecutive annual payout ...

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

Fintel reports that on November 4, 2025, Evercore ISI Group downgraded their outlook for Kimberly-Clark (NasdaqGS:KMB) from ...

Kimberly-Clark announces the acquisition of Kenvue, the maker of Tylenol, in a landmark $48.7 billion deal to create a ...

Evercore also said Kimberly’s move expands its footprint into two stable, cash-generative global categories, personal hygiene and consumer health, that have high barriers to entry and rational pricing ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

For every share of Kenvue stock they possess, they will get $3.50 in cash and 0.15 Kimberly-Clark shares. This makes the deal ...